2/17
06:37 pm
brbi
BR Biopharma (NASDAQ:BRBI) is now covered by analysts at
Weiss Ratings. They set a "sell (e-)" rating on the stock.
Neutral
Report
BR Biopharma (NASDAQ:BRBI) is now covered by analysts at
Weiss Ratings. They set a "sell (e-)" rating on the stock.